1. NW–19
  2. Health Ministry
  3. Former office · May 2025 – July 2026
  4. · Rev. October 2026

Former office · data architecture

350+ registers,
one framework

Germany has more than 350 medical registers, each collecting data on a disease, treatment or implant. The Medical Registers Act, introduced to the Bundestag by Nina Warken in May 2026, was designed to give them common rules — and drew sharp questions about privacy and governance.

Today · separate registersProposed · common layerUses Trauma care in old age Malignant melanoma Rare diseases Implants & devices … 350+ more Medical Registers Act Register directory Uniform quality standards Qualification by a Centre for Medical Registers Rules for linkage Research Quality monitoring Outcome comparison Patient safety Safeguards: consent or objection · pseudonymisation · data-protection review · oversight
Simplified schematic of the bill's logic, drawn for this page. Register names on the left are examples cited in the minister's speech or general categories, not a complete list.
StatusThe Medical Registers Act had passed its first reading and a committee hearing when Nina Warken left the Ministry of Health on 29 July 2026. It had not become law. The bill is now in the hands of her successor, Carsten Linnemann, and the Bundestag. Related: Ministerial record · Health policy · Major initiatives.

Layer 01 · definition

What a medical register is

A medical register is a structured, long-term collection of standardised data about patients who share a condition, a treatment or a medical product. Unlike a clinical trial, which tests one question under controlled conditions for a limited time, a register observes routine care over years: who was treated, how, and with what result.

That makes registers valuable in ways other data sources are not. They show how treatments work outside trial populations — in older patients, in people with several illnesses, or in women and men separately. In her speech at the first reading the minister gave exactly this kind of example: registers can show whether medicines work differently depending on sex or age. They can reveal problems with implants that only emerge after years. And they allow hospitals to compare their results with others, which is the basis of quality improvement.

Germany's registers have grown from many initiatives: medical societies, university hospitals, patient organisations and public bodies. Among the examples she named were the AltersTraumaRegister, which documents the treatment of injured older people, and the Central Malignant Melanoma Register. Some registers have their own statutory basis; many do not.

Layer 02 · the problem

Data that "lie unconnected side by side"

In presenting the bill on 21 May 2026, the minister described register data in Germany as lying unconnected side by side. Three kinds of fragmentation lie behind that phrase.

Legal

Different legal bases

Registers operate under a patchwork of consent forms, state and federal data-protection rules and institutional policies, making it uncertain what data may be used for which purpose.

Technical

Different standards

Variables, formats and coding differ between registers, so data cannot easily be combined or compared — an interoperability problem.

Practical

Burden on clinicians

Doctors often report similar data several times to different registers. The bill promised less bureaucracy for those who report.

Layer 03 · the bill

The Medical Registers Act

German title
Medizinregistergesetz
Government bill
Drucksache 21/5922, 13 May 2026
First reading
21 May 2026, Bundestag
Committee
Health Committee (lead)
Public hearing
10 June 2026
Status, 29 July 2026
Pending
Nina Warken seated at a desk in an office, gesturing as she speaks
Nina Warken in an office conversation.Press photograph · editorial use

The bill sets uniform federal rules for medical registers. Its main elements, as described by the government and in reporting on the hearing:

  • A register directory listing existing medical registers, to create transparency about what data exist.
  • Uniform quality standards for registers across Germany.
  • A Centre for Medical Registers (Zentrum für Medizinregister) to review registers for data protection and data quality before they are qualified under the law.
  • Two routes to data collection: registers can work with informed consent, or — where complete data are needed to avoid distorted results — with an objection model in which patients' data are included unless they opt out.
  • Rules for linkage of register data with each other and with other sources, and simpler reporting for doctors.
„Bundeseinheitliche Regelungen ermöglichen verlässliche Qualitätsstandards für Medizinregister.“
Nina Warken, Federal Minister of HealthFirst reading, Bundestag, 21 May 2026. Source: Federal Government.“Uniform federal rules make reliable quality standards for medical registers possible.”

Layer 04 · scrutiny

What experts told the Health Committee

The public hearing on 10 June 2026 showed broad support for the aim and significant disagreement about the safeguards. Positions as reported by the Bundestag's news service (hib) and netzpolitik.org.

Opportunities

  • Federal Joint Committee (G-BA) an important first step towards research data infrastructure, though data quality still needs to improve.
  • German Medical Association progress towards a more capable, interoperable register landscape.
  • TMF (research data platform) supported planned data linkage and quality improvements.
  • Eva Luise and Horst Köhler Foundation welcomed the bill and asked for a stronger focus on rare diseases, for which registers are of outstanding importance.

Privacy and governance questions

  • Thilo Weichert (Netzwerk Datenschutzexpertise) called the data-protection rules deficient, argued permitted uses extend beyond research to operational purposes with a high risk of misuse, and warned of re-identification through health insurance numbers.
  • German Medical Association also criticised insufficient safeguards and registers holding identifying and pseudonymised data at the same time.
  • BAG Selbsthilfe asked for stronger protection of vulnerable groups, for example people with HIV, and a central objection mechanism.
  • Federal Data Protection Commissioner supported a Greens proposal for an independent trust office, at the Robert Koch Institute, to manage objections and pseudonymisation, and questioned whether the new Centre would be adequately staffed.
  • Bitkom called the qualification process impractical and asked for standardised, automated procedures; the GKV-Spitzenverband noted the absence of mandatory registration for register operators.

Layer 05 · design choices

The trade-offs inside the architecture

Every health-data law has to balance the same principles. The matrix shows where the medical-registers debate placed the tension.

PrincipleCase for more data useCase for more protectionDesign lever
CompletenessConsent-only registers can be biased if certain groups opt in less oftenInclusion without active consent weakens individual controlConsent route vs objection route
InteroperabilityLinked data reveal long-term outcomes no single register can showLinkage raises the risk of re-identificationPseudonymisation; who holds the keys
PurposeQuality monitoring and safety need operational use, not only researchBroad purposes are harder to explain and controlNarrow list of permitted uses
GovernanceA central body can set and enforce standards quicklyOversight needs independence and resourcesMandate and staffing of the Centre; trust office
BurdenSimpler reporting frees clinicians' timeAutomation must not bypass patient rightsStandardised interfaces with audit trails
„Wir schaffen Rechtssicherheit für die Datennutzung.“
Nina Warken, Federal Minister of HealthFirst reading of the Medical Registers Act, 21 May 2026. Source: Federal Government.“We are creating legal certainty for the use of data.”

Context

Part of a wider data agenda

The Medical Registers Act belongs to a series of German and European laws on health data. The Health Data Use Act of 2024 created a framework for research access to health data, and the European Health Data Space regulation, in force since March 2025, will apply in stages from 2027. In July 2026 the cabinet also adopted the GeDIG bill, which would expand the national research data centre. Together these define how data generated in care can be used for research and quality — and under which protections. See Digital health.

Whatever form the law finally takes, its success will depend less on the statute than on implementation: how many registers go through qualification, whether the Centre for Medical Registers has the capacity to review them, and whether patients trust the safeguards enough not to opt out in large numbers.